Cyclin‐dependent kinase (CDK) inhibitors for hormone receptor‐positive advanced breast cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of cyclin‐dependent kinase (CDK) 4/6 inhibitors in the treatment of patients with hormone receptor‐positive advanced breast cancer.

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cochrane Database Syst Rev
Main Authors: Syn, Nicholas LX, Wee, Ian, Wong, Andrea Li‐Ann, Goh, Robby M, Ow, Samuel Guan‐Wei, Lambertini, Matteo, Lee, Soo‐Chin
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2018
Fag:
Medicine General & Introductory Medical Sciences
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6491121/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012919
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker